Popular searches
- Tremove
- Gebrauchsanweisung
- Studie
- Datenblatt
For doctors, centres & support groups
Tremove™ – a new care option for essential tremor
In October 2026, Tremove™ officially launches in Germany, the European Union and other European countries. After several years of development, people with essential tremor now have a new, non-invasive care option that supports them with the challenges of everyday life.
Get in touchView documents
At a glance
What Tremove™ means for your patients
Tremove™ is a Class I medical device in accordance with MDR (EU) 2017/745 and is worn on the wrist – no power supply, no adjustment, ready to use immediately.
1
How it works
A passive vibration damping system made of a high-density metal core and a non-Newtonian fluid reduces the amplitude of involuntary tremor movements at the wrist – across a broad frequency range, with no power, no battery and no charging.
2
Clinical evidence
In a peer-reviewed clinical study published in the journal of the International Parkinson and Movement Disorder Society, tremor intensity fell significantly.
76 %mean reduction
84 %maximum reduction
3
For doctors and centres
With the market launch, we are building collaborations with general practitioners, neurologists, neurology centres and specialist movement disorder clinics. We would be happy to tell you in person about how it works, its use and the clinical evidence, and to provide information material for your patients. Feedback from our first users has been very positive, and demand is growing steadily.
4
For support groups
Support groups and patient organisations do invaluable work for people with tremor and their families. We would be happy to present Tremove™ at your group meetings – in person or online – answer your members' questions and provide information material.
Building evidence together
Observational studies and clinical research
Together with interested doctors, we want to further expand the evidence on Tremove™ – through observational studies and post-market clinical follow-up (PMCF) in accordance with the MDR, starting in Germany and then in other European countries. Please contact us if you are interested in taking part.
Interested in taking partOur roadmap
- October 2026
Official market launch in Germany, the EU and other European countries
- From October 2026
Building collaborations with doctors, neurology centres and support groups
- Ongoing
Preparing reimbursement by health insurers, starting in Germany; observational studies and PMCF
- Expected Q2 2027
Launch of Tremove-Check and Tremove-Cloud
Sneak preview · expected Q2 2027
Tremove-Check and Tremove-Cloud
Making tremor progress visible – for patients and doctors
With the Tremove-Check app, users can see their personal progress with Tremove™. At the same time, the treating doctor gets a clear overview in the Tremove-Cloud portal – even between two appointments. Developed in collaboration with neurologists; the beta version is currently being tested in a study with more than 100 participants, the results of which will be published internationally.
Initial assessmentDetails and everyday questions
Without and with TremoveShort smartphone video
ProgressVisible to patient and doctor
Health data processed in accordance with the GDPR · servers in the EU · not yet available
Get notified at launch
Tremove-Check and Tremove-Cloud are under development and not yet available. Features and timing may change. The video-based documentation does not provide a diagnosis and does not replace clinical assessment. Schematic illustration, no real patient data.
Documents
Downloads
All documents as PDF. We will gladly send you further information material for your practice or group.
Contact
Get in touch
Whether you would like a personal meeting, a presentation at a group meeting or to take part in observational studies – we will get back to you promptly. Fortis Medical GmbH · Erlhofer Straße 61 · 95032 Hof, Germany · kontakt@tremove.eu
Tremove™ is a Class I medical device in accordance with MDR (EU) 2017/745. It does not replace medical treatment. Please read the instructions for use.